Secondary outcomes included changes in waist circumference, lipid profile, liver enzymes, pancreatic enzymes, HbA1c, insulin resistance, and adverse events
Thomas M, Harjutsalo V, Feodoroff M et al (2020) The long-term incidence of hospitalization for ketoacidosis in adults with established T1D-a prospective cohort study
That is the main reason excitement around retatrutide weight loss has grown so quickly
Finally, we summarized studies showing that GLP-1 can enhance cognitive decline by improving synaptic function in the depressive brain
The FDA approval of Zepbound is based on the results of the SURMOUNT-1 and Through these studies, researchers reported that over 72 weeks, participants who took the highest dose of Zepbound lost an average of 48 lbs, and those who took the lowest dose lost an average of 34 lbs
Nitrogenase gene diversity and microbial community structure: a cross-system comparison